ArticleJournal of clinical epidemiology2021
Effect estimates of COVID-19 non-pharmaceutical interventions are non-robust and highly model-dependent.
Article in Journal of clinical epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- A scoping review of COVID-19 modelling studies in Belgium 2020-2024: incorporation of behaviour and lessons learned.Archives of public health = Archives belges de sante publique · 2026Pooled it
- Effectiveness of non-pharmaceutical interventions as implemented in the UK during the COVID-19 pandemic: a rapid review.Journal of public health (Oxford, England) · 2025Pooled it
- Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2023Pooled it
- Methodological assessment of systematic reviews and meta-analyses on COVID-19: A meta-epidemiological study.Journal of evaluation in clinical practice · 2021Pooled it
- Uncertainty and inconsistency of COVID-19 non-pharmaceutical intervention effects with multiple competitive statistical models.Scientific reports · 2026Article
- Neural networks to model COVID-19 dynamics and allocate healthcare resources.Scientific reports · 2025Article
- What Lessons can Be Learned From the Management of the COVID-19 Pandemic?International journal of public health · 2025Review
- Paracetamol Use and COVID-19 Clinical Outcomes: A Meta-Analysis.Healthcare (Basel, Switzerland) · 2024Review
- Non-pharmaceutical interventions to reduce COVID-19 transmission in the UK: a rapid mapping review and interactive evidence gap map.Journal of public health (Oxford, England) · 2024Review
- Mpox: An Overview of Pathogenesis, Diagnosis, and Public Health Implications.Journal of clinical medicine · 2024Review
- Is society caught up in a Death Spiral? Modeling societal demise and its reversal.Frontiers in sociology · 2024Review
- Flaws and uncertainties in pandemic global excess death calculations.European journal of clinical investigation · 2023Review
- COVID-19 and the ecological crisis: What do they have in common?Scandinavian journal of public health · 2023Article
- Do more stringent policies reduce daily COVID-19 case counts? Evidence from Canadian provinces.Economic analysis and policy · 2023Article
- Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities.International journal of environmental research and public health · 2023Review
- Effectiveness of non-pharmaceutical interventions in nine fields of activity to decrease SARS-CoV-2 transmission (Spain, September 2020-May 2021).Frontiers in public health · 2023Article
- What happened to the predicted COVID-19-induced suicide epidemic, and why?The Australian and New Zealand journal of psychiatry · 2023Article
- Modelling the effect of non-pharmaceutical interventions on COVID-19 transmission from mobility maps.Infectious Disease Modelling · 2022Article
- Why do people consent to receiving SARS-CoV-2 vaccinations? A representative survey in Germany.BMJ open · 2022Article
- Increased airborne transmission of COVID-19 with new variants, implications for health policies.Building and environment · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the inference regarding the effectiveness of the various non-pharmaceutical interventions (NPIs) for COVID-19 obtained from different SIR models. STUDY DESIGN AND
settingWe explored two models developed by Imperial College that considered only NPIs without accounting for mobility (model 1) or only mobility (model 2), and a model accounting for the combination of mobility and NPIs (model 3). Imperial College applied models 1 and 2 to 11 European countries and to the USA, respectively. We applied these models to 14 European countries (original 11 plus another 3), over two different time horizons.
resultsWhile model 1 found that lockdown was the most effective measure in the original 11 countries, model 2 showed that lockdown had little or no benefit as it was typically introduced at a point when the time-varying reproduction number was already very low. Model 3 found that the simple banning of public events was beneficial, while lockdown had no consistent impact. Based on Bayesian metrics, model 2 was better supported by the data than either model 1 or model 3 for both time horizons.
conclusionInferences on effects of NPIs are non-robust and highly sensitive to model specification. In the SIR modeling framework, the impacts of lockdown are uncertain and highly model-dependent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.